How frequently should a dual‑energy X‑ray absorptiometry (DEXA) scan and a carotid duplex ultrasound be performed in average‑risk adults, and how do higher risk factors modify the recommended intervals?

DEXA and Carotid Ultrasound Screening Frequency

DEXA Scan Frequency

For average-risk adults, DEXA scans should be performed every 2 years after an initial baseline scan, with annual monitoring reserved exclusively for high-risk patients on bone-depleting medications or with established osteoporosis. 1, 2

Initial Screening Recommendations

• Women ≥65 years should undergo baseline DEXA screening 1, 3
• Men ≥70 years should undergo baseline DEXA screening 1
• Postmenopausal women <65 years with risk factors (family history, smoking, low body weight, prior fracture) warrant screening 1, 3
• Men age 50-70 years with risk factors should be considered for screening 1

Follow-Up Intervals for Average-Risk Patients

• Standard interval: Every 2 years for patients with normal BMD or mild osteopenia without additional risk factors 1, 2
• Extended intervals (3+ years) may be appropriate for truly low-risk patients with normal baseline DEXA and no risk factors 2, 3
• Never more frequently than annually - bone density changes occur slowly and shorter intervals rarely provide clinically meaningful information 1, 2

High-Risk Patients Requiring Annual Monitoring

The following populations warrant annual DEXA scans due to accelerated bone loss:

• Glucocorticoid therapy >3 months - highest risk for rapid bone loss 1, 2
• Aromatase inhibitors (breast cancer patients) - accelerated loss in first 12-24 months 2, 3
• Androgen deprivation therapy (prostate cancer patients) - baseline at 6 months, then annually 2, 3
• Established osteoporosis or fragility fractures - monitoring treatment response 1
• Bariatric surgery patients - malabsorption risk 1
• Chronic inflammatory diseases (rheumatoid arthritis, inflammatory bowel disease) 1
• Prolonged immobilization 1

Critical Technical Considerations

• Always use the same DXA machine for follow-up scans to ensure accurate comparison 1, 3
• Compare BMD values, NOT T-scores between serial scans for accurate assessment of changes 2, 3
• Degenerative spinal changes can falsely elevate BMD values, potentially masking true bone loss 2, 3

---

Carotid Ultrasound Frequency

Routine carotid ultrasound screening is NOT recommended for asymptomatic average-risk adults without clinical manifestations of atherosclerosis. 1, 4

When Initial Screening May Be Reasonable (Class IIa/IIb)

• Asymptomatic patients with carotid bruit - reasonable to perform initial duplex ultrasound 1
• Patients with established atherosclerosis elsewhere (symptomatic PAD, coronary artery disease, aortic aneurysm) - may be considered, though unclear if it affects outcomes 1
• Multiple risk factors (≥2 of: hypertension, hyperlipidemia, smoking, family history of early atherosclerosis) - may be considered, but benefit unclear 1

Surveillance Intervals for Detected Stenosis

If stenosis is detected on initial screening:

• <50% stenosis (mild): Annual surveillance is reasonable, though not indicated in the first year; longer intervals appropriate once stability established 1, 4
• 50-69% stenosis (moderate): Annual ultrasound studies are appropriate 4
• ≥70% stenosis (severe): Ultrasound at 6 months, then every 6-12 months; consider revascularization 4

When Surveillance Should Stop

• Once stability established over extended period, longer intervals or termination of surveillance may be appropriate 1, 4
• If patient's candidacy for intervention has changed (e.g., severe comorbidities precluding surgery), surveillance may be terminated 1, 4
• No disease on initial testing and no risk factors - routine serial imaging not recommended 1, 4

Absolute Contraindications to Routine Screening (Class III)

• Asymptomatic patients without clinical manifestations or risk factors for atherosclerosis 1
• Neurological disorders unrelated to focal cerebral ischemia (brain tumors, degenerative diseases, psychiatric disorders, epilepsy) 1
• Patients with no risk factors and no disease on initial testing 1

Quality Assurance

• All surveillance ultrasounds should be performed by qualified technologists in certified laboratories 1, 4
• Medical therapy (antiplatelet agents, statins, cardiovascular risk factor management) should be optimized for all patients with detected stenosis 4

---

Key Clinical Pitfalls to Avoid

For DEXA:

• Avoid scanning intervals <1 year except in highest-risk patients on bone-depleting medications 1, 2
• Don't compare T-scores between scans - use absolute BMD values 2, 3
• Don't ignore the impact of spinal degenerative changes on lumbar spine BMD 2, 3

For Carotid Ultrasound:

• Don't screen asymptomatic patients without risk factors - no evidence of benefit 1
• Don't continue surveillance indefinitely if stability established and intervention candidacy unchanged 1, 4
• Remember that carotid bruits correlate more with systemic atherosclerosis than significant stenosis 4